Dergiler / Haydarpaşa Numune Medical Journal / 2018 / Cilt: 58 - Sayı: 2

Percutaneous Aortic Valve Replacement for Critical Aortic Stenosis: A Single-Center Experience

Sayfa
61–66
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Transesophageal echocardiography is a complementary and irreplaceable element for cardiac tomography when determining the valve size and operation strategy.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Introduction: This study aimed to assess the procedural success and early term outcomes of percutaneous aortic valve replacement in patients with critical aortic stenosis.
📊
Temel Bulgular & Veri:Methods: This study included patients with severe high-risk aortic stenosis who underwent transcatheter aortic valve replacement between November 2014 and June 2016.
💡
Sonuç & Katkı:Transesophageal echocardiography is a complementary and irreplaceable element for cardiac tomography when determining the valve size and operation strategy.
🔬Tür:Araştırma Makalesi
📍Kapsam:2014 Verileri
⚙️Değişkenler:Alan Parametreleri

Özet

Introduction: This study aimed to assess the procedural success and early term outcomes of percutaneous aortic valve replacement in patients with critical aortic stenosis. Methods: This study included patients with severe high-risk aortic stenosis who underwent transcatheter aortic valve replacement between November 2014 and June 2016. All patients underwent transesophageal echocardiography and cardiac tomography prior to the procedure. The Edwards Sapien XT balloon-expandable transcatheter aortic valve was used in all patients. The valve size was selected according to measurements obtained from cardiac tomography and transesophageal echocardiography. Patients were evaluated for procedural success and adverse effects during hospitalization and a 30-day follow-up period. Results: This study included a total of 33 patients (18 males, 15 females) with a median age of 78.2 (range: 62–92) years. Valve implantation was successfully performed in all patients. The valve size, which was selected according to transesophageal echocardiography, was increased in only one patient following cardiac tomography. Three patients died during the hospitalization period. No further deaths occurred during the 30-day observation period. Discussion and Conclusion: Percutaneous transaortic valve replacement treatment for patients with high-risk aortic stenosis is an efficient and reliable treatment modality. Transesophageal echocardiography is a complementary and irreplaceable element for cardiac tomography when determining the valve size and operation strategy.

🔖

Bu Makaleye Atıf Yap

OVALI, C. (2018). Percutaneous Aortic Valve Replacement for Critical Aortic Stenosis: A Single-Center Experience. Haydarpaşa Numune Medical Journal, Cilt: 58 - Sayı: 2, 61–66. https://ajindex.com/articles/195324

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (13)

  1. Aronow WS, Ahn C, Kronzon I. Comparison of echocardiographic abnormalities in African-American, Hispanic, and white men and women aged >60 years. Am J Cardiol 2001
  2. 1131–3. [CrossRef ] 2. Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez- Sarano M. Burden of valvular heart diseases: a population- based study. Lancet 2006
  3. 1005–11. [CrossRef ] 3. Baumgartner H, Hung J, Bermejo J, Chambers JB, Evangelista A, Griffin BP, et al. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. Eur J Echocardiogr 2009
  4. 1–25. [CrossRef ] 4. Mangner N, Schuler G. ESC guidelines on the management of valvular heart disease. What has changed and what is new? Herz 2013
  5. 828–37. [CrossRef ] 5. Al-Najafi S, Sanchez F, Lerakis S. The Crucial Role of Cardiac Imaging in Transcatheter Aortic Valve Replacement (TAVR): Pre- and Post-procedural Assessment. Curr Treat Options Cardiovasc Med 2016
  6. [CrossRef ] 6. Praz F, Windecker S, Huber C, Carrel T, Wenaweser P. Expanding Indications of Transcatheter Heart Valve Interventions. JACC Cardiovasc Interv 2015
  7. 1777–96. [CrossRef ] 7. Mack MJ, Leon MB, Smith CR, Miller DC, Moses JW, Tuzcu EM, et al. 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet 2015
  8. 2477–84. [CrossRef ] 8. Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, et al
  9. PARTNER Trial. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 2011
  10. 2187–98. [CrossRef ] 9. Webb JG, Altwegg L, Boone RH, Cheung A, Ye J, Lichtenstein S, et al. Transcatheter aortic valve implantation: impact on clinical and valve-related outcomes. Circulation 2009
  11. 3009– 16. [CrossRef ] 10. Wang H, Hanna JM, Ganapathi A, Keenan JE, Hurwitz LM, Vavalle JP, et al. Comparison of aortic annulus size by transesophageal echocardiography and computed tomography angiography with direct surgical measurement. Am J Cardiol 2015
  12. 1568–73. [CrossRef ] 11. Shiota T. Role of echocardiography for catheter-based management of valvular heart disease. J Cardiol 2017
  13. 66–73. 12. Ghatak A, Bavishi C, Cardoso RN, Macon C, Singh V, Badheka AO, et al. Complications and Mortality in Patients Undergoing Transcatheter Aortic Valve Replacement With Edwards SAPIEN & SAPIEN XT Valves: A Meta-Analysis of World-Wide Studies and Registries Comparing the T